Literature DB >> 20498278

c-Fos proteasomal degradation is activated by a default mechanism, and its regulation by NAD(P)H:quinone oxidoreductase 1 determines c-Fos serum response kinetics.

Julia Adler1, Nina Reuven, Chaim Kahana, Yosef Shaul.   

Abstract

The short-lived proto-oncoprotein c-Fos is a component of the activator protein 1 (AP-1) transcription factor. A large region of c-Fos is intrinsically unstructured and susceptible to a recently characterized proteasomal ubiquitin-independent degradation (UID) pathway. UID is active by a default mechanism that is inhibited by NAD(P)H:quinone oxidoreductase 1 (NQO1), a 20S proteasome gatekeeper. Here, we show that NQO1 binds and induces robust c-Fos accumulation by blocking the UID pathway. c-Jun, a partner of c-Fos, also protects c-Fos from proteasomal degradation by default. Our findings suggest that NQO1 protects monomeric c-Fos from proteasomal UID, a function that is fulfilled later by c-Jun. We show that this process regulates c-Fos homeostasis (proteostasis) in response to serum stimulation, phosphorylation, nuclear translocation, and transcription activity. In addition, we show that NQO1 is important to ensure immediate c-Fos accumulation in response to serum, since a delayed response was observed under low NQO1 expression. These data suggest that in vivo, protein unstructured regions determine the kinetics and the homeostasis of regulatory proteins. Our data provide evidence for another layer of regulation of key regulatory proteins that functions at the level of protein degradation and is designed to ensure optimal formation of functional complexes such as AP-1.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20498278      PMCID: PMC2916405          DOI: 10.1128/MCB.00899-09

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  56 in total

1.  Protein domains involved in nuclear transport of Fos.

Authors:  M A Campos; E G Kroon; R Gentz; P C Ferreira
Journal:  Cell Biol Int       Date:  1999       Impact factor: 3.612

2.  Molecular characterization of the thermosensitive E1 ubiquitin-activating enzyme cell mutant A31N-ts20. Requirements upon different levels of E1 for the ubiquitination/degradation of the various protein substrates in vivo.

Authors:  C Salvat; C Acquaviva; M Scheffner; I Robbins; M Piechaczyk; I Jariel-Encontre
Journal:  Eur J Biochem       Date:  2000-06

3.  Why are "natively unfolded" proteins unstructured under physiologic conditions?

Authors:  V N Uversky; J R Gillespie; A L Fink
Journal:  Proteins       Date:  2000-11-15

4.  Intrinsic structural disorder of the C-terminal activation domain from the bZIP transcription factor Fos.

Authors:  K M Campbell; A R Terrell; P J Laybourn; K J Lumb
Journal:  Biochemistry       Date:  2000-03-14       Impact factor: 3.162

5.  Subcellular localization of NAD(P)H:quinone oxidoreductase 1 in human cancer cells.

Authors:  Shannon L Winski; Yiannis Koutalos; David L Bentley; David Ross
Journal:  Cancer Res       Date:  2002-03-01       Impact factor: 12.701

6.  Small maf (MafG and MafK) proteins negatively regulate antioxidant response element-mediated expression and antioxidant induction of the NAD(P)H:Quinone oxidoreductase1 gene.

Authors:  S Dhakshinamoorthy; A K Jaiswal
Journal:  J Biol Chem       Date:  2000-12-22       Impact factor: 5.157

Review 7.  Regulation of genes encoding NAD(P)H:quinone oxidoreductases.

Authors:  A K Jaiswal
Journal:  Free Radic Biol Med       Date:  2000-08       Impact factor: 7.376

8.  Phosphorylation of the carboxyl-terminal transactivation domain of c-Fos by extracellular signal-regulated kinase mediates the transcriptional activation of AP-1 and cellular transformation induced by platelet-derived growth factor.

Authors:  Paula Monje; Maria Julia Marinissen; J Silvio Gutkind
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

9.  c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK.

Authors:  T Deng; M Karin
Journal:  Nature       Date:  1994-09-08       Impact factor: 49.962

10.  Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1.

Authors:  G Asher; J Lotem; B Cohen; L Sachs; Y Shaul
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-23       Impact factor: 11.205

View more
  19 in total

Review 1.  Context-dependent resistance to proteolysis of intrinsically disordered proteins.

Authors:  Marcin J Suskiewicz; Joel L Sussman; Israel Silman; Yosef Shaul
Journal:  Protein Sci       Date:  2011-06-08       Impact factor: 6.725

2.  E3 ligase STUB1/CHIP regulates NAD(P)H:quinone oxidoreductase 1 (NQO1) accumulation in aged brain, a process impaired in certain Alzheimer disease patients.

Authors:  Peter Tsvetkov; Yaarit Adamovich; Evan Elliott; Yosef Shaul
Journal:  J Biol Chem       Date:  2011-01-10       Impact factor: 5.157

3.  The protein level of PGC-1α, a key metabolic regulator, is controlled by NADH-NQO1.

Authors:  Yaarit Adamovich; Amir Shlomai; Peter Tsvetkov; Kfir B Umansky; Nina Reuven; Jennifer L Estall; Bruce M Spiegelman; Yosef Shaul
Journal:  Mol Cell Biol       Date:  2013-05-06       Impact factor: 4.272

4.  Calpain-generated natural protein fragments as short-lived substrates of the N-end rule pathway.

Authors:  Konstantin I Piatkov; Jang-Hyun Oh; Yuan Liu; Alexander Varshavsky
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205

5.  A Signaling Network Controlling Androgenic Repression of c-Fos Protein in Prostate Adenocarcinoma Cells.

Authors:  Eswar Shankar; Kyung Song; Sarah L Corum; Kara L Bane; Hui Wang; Hung-Ying Kao; David Danielpour
Journal:  J Biol Chem       Date:  2016-01-19       Impact factor: 5.157

Review 6.  Targeting HIF-1α Function in Cancer through the Chaperone Action of NQO1: Implications of Genetic Diversity of NQO1.

Authors:  Eduardo Salido; David J Timson; Isabel Betancor-Fernández; Rogelio Palomino-Morales; Ernesto Anoz-Carbonell; Juan Luis Pacheco-García; Milagros Medina; Angel L Pey
Journal:  J Pers Med       Date:  2022-05-05

7.  Combination of a selective activator of the glucocorticoid receptor Compound A with a proteasome inhibitor as a novel strategy for chemotherapy of hematologic malignancies.

Authors:  Ekaterina Lesovaya; Alexander Yemelyanov; Kirill Kirsanov; Alexander Popa; Gennady Belitsky; Marianna Yakubovskaya; Leo I Gordon; Steven T Rosen; Irina Budunova
Journal:  Cell Cycle       Date:  2012-12-19       Impact factor: 4.534

8.  Functional analyses of a human vascular tumor FOS variant identify a novel degradation mechanism and a link to tumorigenesis.

Authors:  David G P van IJzendoorn; Zary Forghany; Frauke Liebelt; Alfred C Vertegaal; Aart G Jochemsen; Judith V M G Bovée; Karoly Szuhai; David A Baker
Journal:  J Biol Chem       Date:  2017-11-17       Impact factor: 5.157

9.  Small Molecule Modulation of Proteasome Assembly.

Authors:  Evert Njomen; Pawel A Osmulski; Corey L Jones; Maria Gaczynska; Jetze J Tepe
Journal:  Biochemistry       Date:  2018-06-27       Impact factor: 3.162

10.  Stress-induced NQO1 controls stability of C/EBPα against 20S proteasomal degradation to regulate p63 expression with implications in protection against chemical-induced skin cancer.

Authors:  B A Patrick; A K Jaiswal
Journal:  Oncogene       Date:  2012-01-16       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.